Detalhe da pesquisa
1.
T-cell recovery and evidence of persistent immune activation 12 months after severe COVID-19.
Allergy
; 77(8): 2468-2481, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35567391
2.
Autoantibodies in COVID-19 correlate with antiviral humoral responses and distinct immune signatures.
Allergy
; 77(8): 2415-2430, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35364615
3.
Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19.
J Allergy Clin Immunol
; 147(2): 545-557.e9, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33221383
4.
Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19.
Allergy
; 76(9): 2866-2881, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33884644
5.
A case series of eight amateur athletes: exercise-induced pre-/syncope during the Zurich Marathon 2023.
Eur Heart J Case Rep
; 8(5): ytae202, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38711684
6.
Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial.
Front Immunol
; 14: 1255292, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37965347
7.
Neutrophile-to-Lymphocyte Ratio (NLR) Identifies Patients with Coronavirus Infectious Disease 2019 (COVID-19) at High Risk for Deterioration and Mortality-A Retrospective, Monocentric Cohort Study.
Diagnostics (Basel)
; 12(5)2022 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35626265
8.
The AIFELL Score as a Predictor of Coronavirus Disease 2019 (COVID-19) Severity and Progression in Hospitalized Patients.
Diagnostics (Basel)
; 12(3)2022 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35328157
9.
Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome.
Nat Commun
; 13(1): 446, 2022 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35078982
10.
Longitudinal Smartphone-Based Post-hospitalisation Symptom Monitoring in SARS-CoV-2 Associated Respiratory Failure: A Multi-Centre Observational Study.
Front Rehabil Sci
; 2: 777396, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-36188784
11.
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).
Trials
; 22(1): 1, 2021 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33397449
12.
A distinct innate immune signature marks progression from mild to severe COVID-19.
Cell Rep Med
; 2(1): 100166, 2021 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33521697
13.
Pearls and Myths in the Evaluation of Patients with Suspected Acute Pulmonary Embolism.
Am J Med
; 132(6): 685-691, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30710540